Citigroup Maintains Buy on Adient, Lowers Price Target to $29
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $33 to $29.
Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $33 to $29.